Agios Stock Rebounds After Mitapivat Hits Key Target in Thalassemia Trial (NASDAQ:AGIO) by Technical Terrence Team 01/03/2024 0 Agios Pharmaceuticals (NASDAQ: AGIO) stocks rose ~33% premarket on Wednesday after a late-stage global trial of mitapivat in adults with ...
New nationwide data shows a significant increase in alerts about self-harm, harm to others, and the presence of weapons on K-12 campuses 02/23/2023